Impact of Caspase3/GSDME-Mediated Pyroptosis on Tumor Immune Microenvironment and Clinical Prognosis Across Multiple Cancers
Cancer Management and Research · 2024-11 · Volume 16 · 1663-1683
DOI: 10.2147/cmar.s492171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Management and Research, 2024-11. Verfasst von YuanLi Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, People's Republic of China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Globally, the disease that has the greatest impact on human health and is the most difficult to overcome is cancer (tumor or malignant tumor is another name for it). Cancers currently known to us can arise from almost any organ or tissue in the human body. Its uncontrolled growth pattern and metastasis characteristics are the fundamental reasons for the high mortality rate of cancer and its current incurability. An increasing number of studies have found that pyroptosis, a mode of programmed cell death, may inhibit tumor growth by changing the tumor immune microenvironment (TIME).
Methods
Through a retrospective study, we selected 160 cases of different tumor tissues (including 40 cases each of esophageal cancer, gastric cancer, breast cancer, and cervical cancer), and identified the expression of caspase3/GasderminE in the tumor tissues through immunohistochemical staining and infiltration of tumor-related immune cells. And analyze its relationship with clinical parameters of tumor patients. In addition, we also marked caspase8 and caspase9 among the caspase family members to analyze the main factors upstream of caspase3.
Results
The results showed that the expression level of caspase3/GSDME in different tumor tissues was positively correlated with the infiltration degree of tumor-related immune cells (natural killer cells, CD8+T cells, macrophages, etc). In addition, the expression level of caspase3 was positively correlated with caspase8, but not caspase9. Summary: The expression levels of caspase3 and GSDME exhibited significant impacts on the survival prognosis of patients with diverse tumors as well as alterations in the immune microenvironment of tumor tissues, demonstrating statistical significance. After Caspase3/GSDME triggers the pyroptosis pathway, it may change the components of the immune microenvironment of tumor tissue, thereby achieving the effect of inhibiting tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, People's Republic of China.
- Graduate School of Bengbu Medical University, Bengbu, Anhui, People's Republic of China.
- Department of Pathology, School of Basic Medicine, Bengbu Medical University, Bengbu, Anhui, People's Republic of China.
Zitieren
APA
Huang, Y., Liu, J., Lin, C., Zhu, Q., & Wu, L. (2024). Impact of Caspase3/GSDME-Mediated Pyroptosis on Tumor Immune Microenvironment and Clinical Prognosis Across Multiple Cancers. Cancer Management and Research, Volume 16, 1663-1683. https://doi.org/10.2147/cmar.s492171
Vancouver
Huang Y, Liu J, Lin C, Zhu Q, Wu L. Impact of Caspase3/GSDME-Mediated Pyroptosis on Tumor Immune Microenvironment and Clinical Prognosis Across Multiple Cancers. Cancer Management and Research. 2024;Volume 16:1663-1683. doi:10.2147/cmar.s492171
BibTeX
@article{Huang2024,
author = {Huang, YuanLi and Liu, JinJie and Lin, ChunLian and Zhu, Qing and Wu, LiGao},
title = {Impact of Caspase3/GSDME-Mediated Pyroptosis on Tumor Immune Microenvironment and Clinical Prognosis Across Multiple Cancers},
journal = {Cancer Management and Research},
year = {2024},
volume = {Volume 16},
pages = {1663--1683},
doi = {10.2147/cmar.s492171}
}
EUVIMED